CloSys Corp. — a St. Paul med-tech that has developed a device for better closing the artery in the groin after a catheterization — is seeking to raise an additional $2.5 million from investors ...

MINNEAPOLIS, MN / ACCESSWIRE / December 8, 2014 / CloSys Corporation announced today new company leadership, including a new CEO and new members of its Board of Directors. The new team will guide ...

A Minnesota startup developing a vascular closure device is looking to raise $2.5 million in debt and options, according to a regulatory filing. It has raised $30,000 so far. CloSys Corp. has been ...

CloSYS launched its new preflavored, alcohol-free oral healthcare rinse at the 2015 Chicago Midwinter Meeting. Offered at the same cost as the company's original unflavored rinse, the new JustRight ...

Rowpar Pharmaceuticals said that an in vitro laboratory analysis found that its CloSys ultrasensitive oral rinse reduced SARS-CoV-2 by up to 98.4% within 30 seconds. The study was conducted at an ...